EORTC Cancer Research Fund
Help drive critical clinical cancer research and give hope to patients and loved ones.
The European Organisation for Research and Treatment of Cancer (EORTC) is an
academic clinical research organisation, which unites cancer research
experts across the globe to define better treatments for patients to prolong survival and improve quality of life. Both international and multidisciplinary, EORTC’s network comprises of over 3,800 members involved in cancer treatment and research in more than 1,000 institutions across 58 countries. Conducting translational research, and phase 2 and 3 trials, EORTC offers an integrated approach to therapeutic strategies and quality of life. EORTC Headquarters, a unique international clinical research infrastructure, are based in Brussels, Belgium, from where its various activities are coordinated and run.
EORTC pushes the boundaries of treatment options to improve patient care. Spanning all cancer types and treatments as well as working across borders, we are currently engaged in 150 trials at distinct stages of development including several practice-changing trials.
The EORTC Cancer Research Fund (ECRF) is the funding arm of this scientific organization with a mission to promote, encourage and support research on the treatment of cancer under the auspices of the EORTC. Unlike commercially driven research, ECRF supports academic clinical cancer research that prioritises therapeutic progress for patients—not profit.
Fundraisers
Official fundraiser
Support urgent clinical cancer research
Here at EORTC, we are proud of our achievements in bringing together clinical cancer research experts from across the globe. Together we define better treatments for patients which can prolong survival and improve quality of life . Our work is only possible thanks to the trust and generosity of donors like you, alongside our dedicated partners and funders. Your support fuels our research, drives scientific discovery and offers hope to patients and loved ones. Why we need you: According to the UN, global cases of cancer are set to rise more than 70% by 2050. In the US alone and for the first time, new cases of cancer are expected to cross the 2 million mark this year. Every cancer type presents clinicians with diverse challenges. Understanding their nature is crucial to finding the most effective drugs and possible cure. Our impact: At EORTC, we take the knowledge generated and tested in the labs directly to the patient. We help find the most appropriate treatment and care options so that no one is left behind. For over 60 years, EORTC has been Europe’s leading organisation in improving cancer outcomes through independent clinical trials. Spanning all cancer types and treatments we work across borders in 58 countries. Currently, we are engaged in 150 trials at distinct stages of development including several practice-changing trials We need your help to keep momentum going: This Giving Tuesday help us continue our mission. Your donation supports independent, nonprofit clinical cancer research—advancing treatments for patients across all cancer types, including rare cancers. Unlike commercially driven research, our work prioritises therapeutic progress for patients above all. Please donate now. Thank you for supporting the future of cancer therapy.
